MHC-restricted phosphopeptides from insulin receptor substrate-2 and CDC25b offer broad-based immunotherapeutic agents for cancer.
about
A Molecular Basis for the Presentation of Phosphorylated Peptides by HLA-B Antigens.The Role of Neoantigens in Naturally Occurring and Therapeutically Induced Immune Responses to Cancer.Lipopeptides: a novel antigen repertoire presented by major histocompatibility complex class I molecules.Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry.Current Strategies to Enhance Anti-Tumour Immunity.
P2860
MHC-restricted phosphopeptides from insulin receptor substrate-2 and CDC25b offer broad-based immunotherapeutic agents for cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
MHC-restricted phosphopeptides ...... therapeutic agents for cancer.
@ast
MHC-restricted phosphopeptides ...... therapeutic agents for cancer.
@en
type
label
MHC-restricted phosphopeptides ...... therapeutic agents for cancer.
@ast
MHC-restricted phosphopeptides ...... therapeutic agents for cancer.
@en
prefLabel
MHC-restricted phosphopeptides ...... therapeutic agents for cancer.
@ast
MHC-restricted phosphopeptides ...... therapeutic agents for cancer.
@en
P2093
P2860
P1433
P1476
MHC-restricted phosphopeptides ...... therapeutic agents for cancer.
@en
P2093
A Nicole Desch
Angela L Zarling
Donna H Deacon
Joel Pinczewski
Kara L Cummings
Mark Conaway
Rebecca C Obeng
P2860
P304
P356
10.1158/0008-5472.CAN-14-0043
P407
P577
2014-10-08T00:00:00Z